- Commodities Weekly - Framing tariff-induced stagflation risks
- African Private Capital Fundraising Doubles to $4bn in 2024
- The Rise of Contemporary African Art in a Global Market - Marelize van Zyl
- 21st Edition Connected Banking Summit – Innovation & Excellence Awards 2025
- Afreximbank delivered exceptional 2024 financial performance
Nigeria Approves AstraZeneca Vaccines for Emergency Use
LAGOS (Capital Markets in Africa) — Nigerian regulators approved a coronavirus vaccine that was developed by AstraZeneca Plc and the University of Oxford for emergency use in the West African nation. “The Serum Institute of India Ltd. on Feb. 10 submitted a dossier on the Covishield vaccine, which it is producing under license from AstraZeneca, and it was found to be safe and well-tolerated in adults above 18 years of age, the National Agency for…
Read More